— Know what they know.
Not Investment Advice
Also trades as: QIA.DE (XETRA) · $vol 29M

QGEN NYSE

Qiagen N.V.
1W: +1.3% 1M: +1.2% 3M: +15.3% YTD: -1.1% 1Y: -3.4% 3Y: +13.3% 5Y: -17.4%
$44.75
+2.71 (+6.45%)
 
Weekly Expected Move ±5.6%
$40 $42 $45 $47 $50
NYSE · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 52 · $9.2B mcap · 205M float · 1.29% daily turnover · Short 45% of daily vol

Cash Flow Trends

Operating Cash Flow
$654M -2.9% ▼
5Y CAGR: +5.9%
Capital Expenditures
$201M -20.3% ▼
5Y CAGR: -8.0%
Free Cash Flow
$453M -10.5% ▼
5Y CAGR: +19.2%
Dividends Paid
$54M +0.0% ▲
Buybacks
$307M -5.2% ▼
Net Change in Cash
$175M +3973.9% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$513M$423M$341M$84M$425M
Depreciation & Amort.$215M$208M$205M$203M$197M
Stock-Based Comp.$38M$50M$47M$44M$50M
Change in Working Capital-$130M-$32M-$187M$135M-$35M
Other Non-Cash Items$8M$76M$42M$231M$37M
Operating Cash Flow$639M$715M$459M$674M$654M
— Investing Activities —
Capital Expenditures-$207M-$149M-$163M-$167M-$207M
Acquisitions (Net)-$17M-$64M-$150M$0-$291M
Investment Purchases-$400M-$1.4B-$979M-$688M-$372M
Investment Sales$360M$883M$1.3B$585M$597M
Other Investing$61M-$10M-$67M$21M-$32M
Investing Cash Flow-$202M-$727M-$88M-$249M-$305M
— Financing Activities —
Net Debt Issuance-$41M-$109M-$437M-$107M$208M
Stock Repurchased-$100M$0$0-$292M-$307M
Dividends Paid$0$0$0$0-$54M
Other Financing-$17M-$17M$3M-$23M-$26M
Financing Cash Flow-$150M-$126M-$434M-$423M-$179M
Net Change in Cash$283M-$150M-$63M-$5M$175M
Cash End of Period$881M$731M$668M$664M$839M
Free Cash Flow$432M$566M$297M$506M$453M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms